260 related articles for article (PubMed ID: 26291684)
21. An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling.
El Malki K; Karbach SH; Huppert J; Zayoud M; Reissig S; Schüler R; Nikolaev A; Karram K; Münzel T; Kuhlmann CR; Luhmann HJ; von Stebut E; Wörtge S; Kurschus FC; Waisman A
J Invest Dermatol; 2013 Feb; 133(2):441-51. PubMed ID: 22951726
[TBL] [Abstract][Full Text] [Related]
22. Oral Administration of Vanillin Improves Imiquimod-Induced Psoriatic Skin Inflammation in Mice.
Cheng HM; Chen FY; Li CC; Lo HY; Liao YF; Ho TY; Hsiang CY
J Agric Food Chem; 2017 Nov; 65(47):10233-10242. PubMed ID: 29073354
[TBL] [Abstract][Full Text] [Related]
23. The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression.
Palomo J; Troccaz S; Talabot-Ayer D; Rodriguez E; Palmer G
PLoS One; 2018; 13(3):e0194667. PubMed ID: 29554104
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of imiquimod-induced psoriasis-like dermatitis in mice by herbal extracts from some Indian medicinal plants.
Arora N; Shah K; Pandey-Rai S
Protoplasma; 2016 Mar; 253(2):503-15. PubMed ID: 26016607
[TBL] [Abstract][Full Text] [Related]
25. Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation.
Nadeem A; Al-Harbi NO; Al-Harbi MM; El-Sherbeeny AM; Ahmad SF; Siddiqui N; Ansari MA; Zoheir KM; Attia SM; Al-Hosaini KA; Al-Sharary SD
Pharmacol Res; 2015 Sep; 99():248-57. PubMed ID: 26149470
[TBL] [Abstract][Full Text] [Related]
26. Surgical Denervation in the Imiquimod-Induced Psoriasiform Mouse Model.
Onderdijk AJ; Hekking-Weijma IM; Florencia EF; Prens EP
Methods Mol Biol; 2017; 1559():75-81. PubMed ID: 28063038
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-21 receptor signalling is not critically required for imiquimod-induced psoriasiform dermatitis in mice.
Kim HJ; Kim SH; Kim TG; Park JY; Lee M; Kim DS; Lee MG
Exp Dermatol; 2018 Feb; 27(2):191-195. PubMed ID: 29220875
[TBL] [Abstract][Full Text] [Related]
28. Gold lotion from citrus peel extract ameliorates imiquimod-induced psoriasis-like dermatitis in murine.
Lin CC; Wu JJ; Pan YG; Chao YH; Lin FC; Lee YR; Chu CL
J Sci Food Agric; 2018 Nov; 98(14):5509-5517. PubMed ID: 29691866
[TBL] [Abstract][Full Text] [Related]
29. Anti-IL-12/IL-23p40 antibody ameliorates dermatitis and skin barrier dysfunction in mice with imiquimod-induced psoriasis-like dermatitis.
Takahashi T; Koga Y; Kainoh M
Eur J Pharmacol; 2018 Jun; 828():26-30. PubMed ID: 29544684
[TBL] [Abstract][Full Text] [Related]
30. Reduction of CD18 promotes expansion of inflammatory γδ T cells collaborating with CD4+ T cells in chronic murine psoriasiform dermatitis.
Gatzka M; Hainzl A; Peters T; Singh K; Tasdogan A; Wlaschek M; Scharffetter-Kochanek K
J Immunol; 2013 Dec; 191(11):5477-88. PubMed ID: 24190659
[TBL] [Abstract][Full Text] [Related]
31. The circadian clock Period 2 gene regulates gamma interferon production of NK cells in host response to lipopolysaccharide-induced endotoxic shock.
Liu J; Malkani G; Shi X; Meyer M; Cunningham-Runddles S; Ma X; Sun ZS
Infect Immun; 2006 Aug; 74(8):4750-6. PubMed ID: 16861663
[TBL] [Abstract][Full Text] [Related]
32. Mitomycin C modulates the circadian oscillation of clock gene period 2 expression through attenuating the glucocorticoid signaling in mouse fibroblasts.
Kusunose N; Matsunaga N; Kimoto K; Akamine T; Hamamura K; Koyanagi S; Ohdo S; Kubota T
Biochem Biophys Res Commun; 2015 Nov; 467(1):157-63. PubMed ID: 26403971
[TBL] [Abstract][Full Text] [Related]
33. Blockade of phosphatidylinositol 3-kinase PI3Kδ or PI3Kγ reduces IL-17 and ameliorates imiquimod-induced psoriasis-like dermatitis.
Roller A; Perino A; Dapavo P; Soro E; Okkenhaug K; Hirsch E; Ji H
J Immunol; 2012 Nov; 189(9):4612-20. PubMed ID: 23024273
[TBL] [Abstract][Full Text] [Related]
34. Clock-controlled StAR's expression and corticosterone production contribute to the endotoxemia immune response.
Wang J; Luo Y; Wang K; Wang Y; Zhang X; Teng H; Sun Z
Chronobiol Int; 2015 Apr; 32(3):358-67. PubMed ID: 25421094
[TBL] [Abstract][Full Text] [Related]
35. Effects of Human Mesenchymal Stem Cells Transduced with Superoxide Dismutase on Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice.
Sah SK; Park KH; Yun CO; Kang KS; Kim TY
Antioxid Redox Signal; 2016 Feb; 24(5):233-48. PubMed ID: 26462411
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic and immunomodulatory effects of glucosamine in combination with low-dose cyclosporine a in a murine model of imiquimod-induced psoriasis.
Kim CH; Kim JY; Lee AY
Eur J Pharmacol; 2015 Jun; 756():43-51. PubMed ID: 25796200
[TBL] [Abstract][Full Text] [Related]
37. High-fat diet exacerbates imiquimod-induced psoriasis-like dermatitis in mice.
Higashi Y; Yamakuchi M; Fukushige T; Ibusuki A; Hashiguchi T; Kanekura T
Exp Dermatol; 2018 Feb; 27(2):178-184. PubMed ID: 29247486
[TBL] [Abstract][Full Text] [Related]
38. GILZ regulates Th17 responses and restrains IL-17-mediated skin inflammation.
Jones SA; Perera DN; Fan H; Russ BE; Harris J; Morand EF
J Autoimmun; 2015 Jul; 61():73-80. PubMed ID: 26077873
[TBL] [Abstract][Full Text] [Related]
39. A comparison of the effects of topical treatment of calcipotriol, camptothecin, clobetasol and tazarotene on an imiquimod-induced psoriasis-like mouse model.
Sun J; Dou W; Zhao Y; Hu J
Immunopharmacol Immunotoxicol; 2014 Feb; 36(1):17-24. PubMed ID: 24286371
[TBL] [Abstract][Full Text] [Related]
40. Paeonol ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice by inhibiting the maturation and activation of dendritic cells.
Meng Y; Wang M; Xie X; Di T; Zhao J; Lin Y; Xu X; Li N; Zhai Y; Wang Y; Li P
Int J Mol Med; 2017 May; 39(5):1101-1110. PubMed ID: 28339016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
